Skip to Content

Guaifenesin / hydromorphone Pregnancy and Breastfeeding Warnings

Guaifenesin / hydromorphone is also known as: Dilaudid Cough Syrup

Guaifenesin / hydromorphone Pregnancy Warnings

Guaifenesin and hydromorphone has been assigned to pregnancy category C by the FDA. Animal reproduction studies have not been conducted on this combination product. There are no controlled data on this combination product in human pregnancy. Guaifenesin-hydrocodone is only recommended for use during pregnancy when benefit outweighs risk.

See references

Guaifenesin / hydromorphone Breastfeeding Warnings

There are no data on the excretion of guaifenesin and hydromorphone into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue guaifenesin and hydromorphone, taking into account the importance of guaifenesin and hydromorphone to the mother.

See references

References for pregnancy information

  1. "Product Information. Dilaudid Cough Syrup (guaifenesin-hydromorphone)" Knoll Pharmaceutical Company, Mount Olive, NJ.

References for breastfeeding information

  1. "Product Information. Dilaudid Cough Syrup (guaifenesin-hydromorphone)" Knoll Pharmaceutical Company, Mount Olive, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide